Surgery plus drugs may extend life in advanced liver cancer, new trial to find out
NCT ID NCT07537959
First seen May 08, 2026 · Last updated May 20, 2026 · Updated 2 times
Summary
This study looks at people with liver cancer that has spread outside the liver. It tests whether surgically removing the main liver tumor, along with standard drug therapy, helps them live longer compared to drug therapy alone. About 280 adults aged 18-75 with a resectable liver tumor and at least one measurable metastasis will be randomly assigned to one of the two groups. The main goal is overall survival, and the study also tracks side effects and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.